NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What does Pembrolizumab target to treat cancer?

Protein synthesis
Angiogenesis
Immune system
Cell cycle progression

The correct answer is: Immune system

Pembrolizumab is a type of immunotherapy drug known as a checkpoint inhibitor. It works by targeting and blocking a protein called PD-1 on T cells, which are part of the immune system. By blocking PD-1, pembrolizumab helps the immune system recognize and attack cancer cells. This mechanism makes option C, Immune system, the correct answer. Options A, B, and D are incorrect because Pembrolizumab does not target protein synthesis, angiogenesis, or cell cycle progression to treat cancer. It specifically targets the immune system to enhance the body's ability to fight cancer cells.